Promising Silver-Based Anti-Cancer Drugs Discovered (VIDEO) University of Johannesburg This video is under embargo. Please login to access this video. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video Caption A family of economical silver-based complexes show very promising results against a number of human cancers in laboratory tests, with very low toxicity in rat studies and minimal effects on healthy cells. One of these, UJ3, is as effective as the industry-standard drug Cisplatin in killing cancer cells in laboratory tests done on human esophageal cancer, breast cancer and melanoma. Dr Zelinda Engelbrecht, from the University of Johannesburg, shows how UJ3 targets mitochondria inside cancer cells. Credit Dr Zelinda Engelbrecht, Ms Therese van Wyk at the University of Johannesburg. Usage Restrictions None License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.